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Abstract. In the ﬁeld of radiation therapy, much of the research is aimed at developing new and
innovative techniques for treating cancer patients with radiation. In recent years, new
treatment machines have been developed that provide a much greater degree of computer
control than was available with the machines of previous generations. One innovation has
been the development of an approach called “tomotherapy.” Tomotherapy can be deﬁned
as computer-controlled rotational radiotherapy delivered using an intensity-modulated fan
beam of radiation.
The successful implementation of the new delivery techniques requires the development
of a suitable approach for optimizing each patient’s treatment plan. One of the challenges is
to quantify optimality in radiation therapy. We have tested a variety of objective functions
and constraints in pursuit of a formulation that performs well for a wide variety of disease
sites. An additional challenge stems from the sizable amount of data and the large number
of variables that are involved in each optimization. This paper presents several approaches
to optimizing treatment plans in radiation therapy, and the advantages and disadvantages
of a number of formulations are explored.
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1. Introduction. This year in the United States more than 1,200,000 people will
be diagnosed with cancer [55]. More than half of these cancer patients will be treated
with radiation at some point during the course of their disease [66]. Radiotherapy
refers to the use of radiation as a means for treating disease.
A beam of radiation is attenuated as it passes through a patient, and energy is
deposited at each location along the path of the beam. The patient’s dose is the
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amount of energy deposited per unit mass. High doses of radiation can kill cells
or prevent them from growing and dividing. This is true of both cancer cells and
normal cells. Radiotherapy is a useful tool for treating cancer, because the repair
mechanism of cancer cells is less eﬃcient than that of normal cells. Thus, normal
cells are more likely to fully recover from the eﬀects of radiation. The treatments are
carefully planned so that the radiation damage is concentrated within the cancerous
region [62]. If all of the tumor cells are killed, the patient is cured.
In recent years, advances in radiation therapy have led to the development of
delivery techniques with a high degree of computer control. These techniques oﬀer
many new opportunities in the delivery of radiation therapy. Due to the complexity
of the treatments, however, an optimization approach is needed in order to develop
the best plan for treating each patient.
When designing a patient’s treatment plan, the goal is to provide the highest
probability of tumor control while maintaining an acceptable probability of radiation-
induced complications. Unfortunately, it is very diﬃcult to quantify optimality in
radiation therapy. Over years of practice, physicians develop insights into what is
“optimal” for a particular type of cancer in a particular location. The physician must
also consider the patient’s medical history and the institution’s capabilities. Thus,
it is important that the optimization approach provide the physician with suﬃcient
ﬂexibility so that he or she can always produce an acceptable treatment plan. In
pursuit of a suitable approach for optimizing each patient’s treatment plan, we have
tested a variety of mathematical programming approaches to this problem. This
paper outlines the advantages, the disadvantages, and the quality of the solutions
that are produced using each of these approaches. It is hoped that this research will
provide insights to both developers of optimization technology and physicians about
the potential capabilities of a carefully devised optimization approach.
This project made use of two mathematical software packages, MATLAB [48] and
GAMS [9]. MATLAB was chosen because of its capabilities in both numeric compu-
tation and advanced graphic visualization. GAMS, the General Algebraic Modeling
System, was chosen because of its strength as a tool for eﬃciently performing large-
scale optimizations. This environment provided a means for eﬃciently testing models
that varied widely in terms of both the complexity of formulation and the time re-
quired to obtain an optimal solution.
A simulated “patient” was represented by an all-water cylinder, and the opti-
mizations were performed for a single transverse cross section of the patient. This
simple setup was used in order to speed up the dose computations [70]. Although
actual patient data can be used with our algorithms, our initial investigation into a
variety of optimization techniques did not require that level of complexity. Through-
out this work, we have used precomputed photon beamlets as a means of testing a
large number of objective functions and constraints [60, 7].
Section 2 of this paper provides an overview of radiation therapy and conventional
delivery techniques. Section 3 introduces the more advanced delivery techniques that
have been developed in recent years. These delivery techniques provide the user with
a large number of “beamlets” of radiation, each of which is assigned a separate beam
intensity. One of these techniques, tomotherapy, is described in detail.
Section 4 of this paper presents the results of an investigation into a variety of
optimization approaches for determining each patient’s treatment plan. Linear pro-
gramming formulations are discussed in section 4.1. One linear programming approach
is to minimize the total dose delivered to the patient subject to a lower bound on theOPTIMIZING THE DELIVERY OF RADIATION THERAPY 723
Fig. 2.1 The dose distribution from a single beam of radiation. The highest dose level appears at
the top of the picture, because the beam enters from the top. The outer circle represents
the outline of the patient, and the inner circle denotes the outline of the tumor.
dose to the tumor and an upper bound on the mean dose to the region at risk. Lin-
ear programming formulations such as this can be solved very eﬃciently, particularly
when modeling tools and optimization packages are used. Nonlinear optimization
approaches are described in section 4.2. These formulations are primarily based on a
weighted least squares approach. Section 4.3 presents two implementations of partial
volume constraints. One implementation is based on the use of a nonlinear ramp
function, and the second is based on mixed integer programming (MIP). Extensions
of our models to conformal avoidance problems are provided in section 4.4. Section 5
draws some conclusions and outlines research challenges in this area.
2. Conventional Radiotherapy. An appreciation of how a beam of radiation
is attenuated in a human body helps one to better understand radiation therapy.
Figure 2.1 presents the distribution of dose from a single beam of radiation. More
speciﬁcally, it shows the dose to the central slice of a 20-cm-diameter all-water cylin-
der irradiated with 2-MeV x-ray photons. This ﬁgure can be thought of as a simplistic
representation of a transverse cross section through a patient. The inner circle de-
notes the outline of the tumor. If we were to treat a patient with a single beam of
radiation, it might be possible to kill all of the tumor cells. Unfortunately, however,
we would also risk severe damage to any normal tissues located within the path of
the beam of radiation. To avoid this, beams are delivered from a number of diﬀerent
angles spaced around the patient.
In Figure 2.2, a dose distribution from the delivery of ﬁve equispaced beams of
radiation is shown. Note that the dose to the tumor is signiﬁcantly higher than the
dose to the surrounding normal tissues. This is a result of the fact that the beams
intersect within the tumor.
The vast majority of patients who receive radiation are treated on a machine
called a linear accelerator (see Figure 2.3). The patient lies on the couch of the
treatment unit. The x-rays produced by the linear accelerator are ﬁltered so that the
beam of x-rays is uniform in intensity as it exits the machine. The x-rays are then
shaped into a beam of radiation that is directed toward the patient. The head of
the linear accelerator can be rotated around the patient. This provides the ability to
treat the patient from a wide range of beam directions.724 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
Fig. 2.2 A dose distribution created with ﬁve equispaced beams. Note that the dose is concentrated
in the tumor, where the beams intersect.
Fig. 2.3 A clinical linear accelerator used to treat cancer patients.
Radiotherapy patients are typically treated with between three and seven beams
of radiation. Through an iterative process of trial and error, a radiation oncologist
and a physicist determine an acceptable set of beam angles and beam weights that
produces an acceptable treatment plan. The beam angles, the beam intensities, and
the predicted dose distribution together make up the treatment plan. In conventional
treatments, a uniform or linearly varying beam intensity is delivered from each beam
angle.
Figure 2.4 shows three treatment plans developed using conventional uniform
beam delivery. In all three cases, seven equispaced beam angles were used. Fig-
ure 2.4(a) shows the optimized dose distribution for a simple square-shaped target
with a smaller square shaped region at risk located adjacent to the target. Fig-
ure 2.4(b) shows the dose distribution for a target of intermediate complexity. The
target is L-shaped with a region at risk located between the arms of the L. Figure 2.4(c)
shows the dose distribution for a complex target shape. The target is U-shaped with
a region at risk placed in the concavity of the U. This type of geometry would be seen
clinically if a tumor had grown around a patient’s spinal cord or brain stem.
In Figure 2.4, the dashed line represents the 90% isodose curve. This line indicates
a dose level that is equal to 90% of the dose prescribed to the target. Ideally, thisOPTIMIZING THE DELIVERY OF RADIATION THERAPY 725
(a) Simple: Square Target (b) Intermediate: L-Shaped Target
(c) Complex: U-Shaped Target
Fig. 2.4 Three treatment plans developed using uniform beam delivery. Seven equispaced beam an-
gles were used. Unmodulated ﬁelds were used with the ﬁeld size set to match to target
dimensions. The dashed line represents the 90% isodose curve. This line indicates a dose
level equal to 90% of the prescribed dose to the target.
line should closely match the boundary of the target. The 90% isodose curve is shown
as a dashed line in a number of ﬁgures throughout this paper. It can be seen in
Figure 2.4(a) that uniform beam delivery is able to closely match the 90% isodose
line with the border of the square-shaped target. Figures 2.4(b) and 2.4(c) reveal that
uniform beam delivery does not permit the sparing of a region at risk located in the
concavity of a more complex target shape. Because of the high dose to the region at
risk, this treatment could lead to a high probability of complications.
A simple method for decreasing the probability of normal tissue complications is
to block any portion of a beam that passes through a region at risk. This is referred
to as segmented beam delivery. Figure 2.5 displays three treatment plans developed
using segmented beam delivery. Segmented beam delivery is of particular importance
in cases where it is essential to avoid complications. For example, physicians often
choose to block out any portion of a beam that passes through a patient’s spinal cord.
This is done in order to eliminate the possibility of radiation-induced paralysis.
In all three cases shown in Figure 2.5, segmented beam delivery was successful at
sparing the region at risk. It should be noted, however, that with the intermediate726 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
(a) Simple: Square Target (b) Intermediate: L-Shaped Target
(c) Complex: U-Shaped Target
Fig. 2.5 Three treatment plans developed using segmented beam delivery. Seven equispaced beam
angles were used. Open and unmodulated ﬁelds were used, and the portion of the ﬁeld
passing through the region at risk was blocked out.
and complex target shapes, portions of the tumor were signiﬁcantly underdosed. The
areas of underdosage could permit the survival of some of the cancer cells, and this
could eventually lead to a recurrence of the disease. More complex treatment plans
to alleviate these problems will be described in what follows.
3. IMRT and Tomotherapy. In recent years, the ability to pinpoint the size,
shape, and location of a patient’s tumor has been dramatically improved by the
development of computed tomography (CT) and magnetic resonance imaging (MRI).
In radiotherapy, much of the current research is aimed at developing better hardware
that will make it possible to take full advantage of these improved imaging capabilities.
Independent investigation performed by Brahme [5] and Cormack [16, 17] demon-
strated that the use of nonuniform beam intensities permits the delivery of dose distri-
butions that conform to the target shape while simultaneously sparing any neighbor-
ing regions at risks. Recent technological advances have made possible the delivery
of intensity modulated radiation therapy (IMRT) [71, 26, 4, 40, 3, 8, 22, 49, 11, 75].
In IMRT, each treatment beam has an individually deﬁned intensity distribution. In
other words, one can think of each beam as being divided into a large number ofOPTIMIZING THE DELIVERY OF RADIATION THERAPY 727
(a) Simple: Square Target (b) Intermediate: L-Shaped Target
(c) Complex: U-Shaped Target
Fig. 3.1 Three treatment plans developed using IMRT. Seven equispaced beam angles were used with
a beamlet size of 6 mm.
smaller beamlets of radiation. The weights of these beamlets can be optimized so as
to produce the most favorable dose distribution [70, 67, 6, 2, 29, 30, 31, 50, 61, 60,
43, 15, 12, 20].
Figure 3.1 shows three dose distributions produced using IMRT with seven equi-
spaced beam angles. Approximately 80 beamlets were used in each of these cases. It
can be seen that for all three setups, IMRT was able to successfully conform the 90%
isodose line to the outline of the target shape. Thus, the region at risk was spared
without reducing the probability of tumor control.
The development of IMRT represents an important step in the realization of
conformal therapy. The goal of conformal therapy is the delivery of a high dose
of radiation to the tumor while simultaneously sparing any neighboring regions at
risk. Successful delivery of conformal therapy should allow for an escalation of the
tumor dose and may enhance local tumor control [41]. The dosimetric advantage of
conformal therapy can also be used as a means of providing a reduced probability of
normal tissue complications [28].
One approach to the delivery of IMRT is called tomotherapy (see Figure 3.2) [45,
46, 77, 1, 23]. A number of key features distinguish tomotherapy from conventional728 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
Fig. 3.2 An artist’s rendering of a tomotherapy machine.
Fig. 3.3 In the housing of the tomotherapy machine, the fan beam of radiation passes through a
multileaf collimator. Each leaf of the collimator can be used to block a portion of the beam.
The collimator is binary in nature, meaning each leaf is either in the ﬁeld or out of the
ﬁeld.
treatments. One characteristic of tomotherapy is the use of a rotational treatment
delivery. The linear accelerator is mounted on a ring-shaped gantry, and it progresses
around the patient at a constant speed.OPTIMIZING THE DELIVERY OF RADIATION THERAPY 729
Tomotherapy is also distinguished by the size of the beam that is used to treat
the patient. Tomotherapy does not make use of a broad beam of radiation. Instead,
the beam is collimated into a fan beam that delivers radiation to a narrow slice of
the patient. Over the course of the treatment the fan beam is able to treat the entire
tumor volume. This is accomplished through the use of a moving couch. The patient
lies on the couch of the tomotherapy unit and is slowly advanced through the rotating
fan beam of radiation.
Within the housing of the machine, the fan beam passes through a device called
a multileaf collimator (see Figure 3.3). The collimator has a series of high-density
leaves, and each leaf can be used to block out a portion of the fan beam. As the linear
accelerator progresses around the patient, the leaves move into and out of the beam.
Each full rotation of the linear accelerator can be approximated as a series of
discrete steps. The amount of time that an individual leaf is open during a step is a
variable that is referred to as a beam weight. Through optimizing the beam weights,
it is possible to deliver a dose distribution that closely conforms to the target shape.
Tomotherapy promises to provide a number of enhancements in addition to its
improved beam-delivery capabilities. For example, a tomotherapy machine will be
able to produce CT images of the patient [69]. Another feature of tomotherapy
is that it will provide precise registration capabilities designed to ensure that the
location of the patient on the treatment couch is consistent from day to day [25].
The hardware in the tomotherapy machine will also provide a means of obtaining
an accurate reconstruction of the dose delivered to the patient. Thus, any variation
between the delivered and the predicted dose distributions can be compensated for in
subsequent treatments [63].
4. Optimization Approaches. IMRT treats each patient with thousands or even
tens of thousands of beamlets of radiation. Due to the large number of beams and
the range of intensities involved, a computer-based optimization routine is required in
order to develop each patient’s optimal treatment plan. The remainder of this paper
is devoted to investigating this issue.
As outlined in section 1, it is diﬃcult to quantify the goals of radiation therapy.
Radiation oncologists often use a cumulative dose volume histogram as a means of
determining the quality of a treatment plan (see Figure 4.1). A cumulative dose
volume histogram displays the fraction of the patient that receives at least a speciﬁed
dose level.
The ﬁrst step in the development of a treatment plan is to deﬁne the location of
the tumor and the regions at risk (critical structures). Next, the dose to the patient
from each individual beamlet is computed. The matrix D represents the total dose
delivered to a transverse cross section of the patient, and it equals the sum over all of
the beamlets p of the beam weight multiplied by its corresponding dose matrix Dp:
Dij =
n 
p=1
wpD
p
ij, (4.1)
where n is the number of beamlets, i and j are the pixel coordinates, and wp are
the beamlet weights. The dose matrices were computed using the convolution/super-
position technique. This technique was chosen because of its ability to accurately
model complex dose distributions [47, 65].
Originally, the dose optimizations were performed using the routines provided in
MATLAB’s Optimization Toolbox. MATLAB’s algorithms performed reasonably well730 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
Fig. 4.1 A dose volume histogram from an optimized treatment plan.
for small-scale optimization problems. As the number of beamlets increased, however,
the problems became too large for MATLAB to solve in a reasonable amount of time.
Another concern was the fact that physicians may need to make a number of changes
in the parameters of an optimization before they are satisﬁed with the treatment plan.
Therefore, the speed of each technique is an important concern. We thus turned to
GAMS in hopes of increasing our optimization capabilities.
The development of an optimal treatment plan is made particularly challenging
as a result of the large number of variables and the sizable amount of data that are
involved in each optimization. For our simulated treatments, the dose distribution for
each beamlet was stored in a relatively dense 100 by 100 matrix. Up to 7,000 beamlets
were used in an optimization. Currently, each simulated treatment is set up within
MATLAB and a simple interface [24] is used to pass the data to GAMS. Selecting or
changing the problem formulations is very simple in a modeling language environment.
The user can choose between linear, nonlinear, and mixed integer models. GAMS
also provides the ability to switch between a number of commercial solvers including
OSL [32], CPLEX [33], CONOPT [21], and MINOS [56]. All of these solvers are
very sophisticated large-scale implementations of state-of-the-art algorithms for their
respective problem classes. The advantages of easy problem formulation, modiﬁcation,
and automatic diﬀerentiation far outweigh the slight overhead imposed by a modeling
language. We believe that only after a particular optimization approach becomes
prevalent would it make sense to use one of these solvers exclusively.
At the end of each simulated treatment, the optimized beam weights were returned
from GAMS to MATLAB using the aforementioned interface. MATLAB was then
used to visualize and analyze the results. Many of the ﬁgures shown in this paper
were produced using standard MATLAB graphics utilities along with the optimization
results generated using GAMS. The analysis of the results included a determination
of the mean, minimum, and maximum doses to each region. The standard deviation
in dose over the target was also determined and the dose values were displayed using
a histogram.
The advantages and disadvantages of a number of approaches were tested and the
results are described in the following subsections.OPTIMIZING THE DELIVERY OF RADIATION THERAPY 731
4.1. Linear Programming Approaches. The most widely used mathematical
programming formulation is undoubtedly the linear program [13, 18, 57]. The linear
programming problem is of the form
min cTx
subject to Ax ≥ b,
  ≤ x ≤ u,
where x is the vector of continuous decision variables, cTx describes the linear ob-
jective function, Ax ≥ b represents the set of constraints, and   and u are vectors of
lower and upper bounds on the variables. Linear programming codes have successfully
solved many large-scale optimization problems, using either sophisticated implemen-
tations of the simplex method [13, 18, 59, 64] or adaptations of primal–dual interior
point methods [76].
There are a number of potential linear programming approaches to radiotherapy
dose optimization [68]. One linear programming formulation is to minimize the total
integral dose subject to a lower bound on the dose to the tumor. The integral dose is
the total dose summed over all of the pixels. Using the notation from (4.1), this can
be reformulated as follows:
minw

(i,j) Dij
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),
γ ≤ Dkl ∀(k,l) ∈T,
wp ≥ 0,
where T is the subset of the pixels located in the tumor, n is the number of beamlets,
and γ is the lower bound on the dose to the tumor. A nonnegativity constraint is
placed on the beam weights. The above formulas are designed so that the optimizer
will drive the tumor dose down to the speciﬁed lower bound. The results from a
simulation using this approach are shown in Figure 4.2(a).
The objective function can be modiﬁed so as to minimize a weighted integral dose:
θT

(i,j)∈T
Dij + θR

(i,j)∈R
Dij + θN

(i,j)∈N
Dij.
R is the subset of pixels in the region at risk, and N is the subset of normal tissue
pixels (those located outside both the target and the sensitive structures). In this
formulation, a weighting factor is assigned to each region of the patient. θT is the
target weight, θR is the region at risk weight, and θN is the normal tissue weight.
The objective function equals the sum over the entire volume of each pixel’s dose
multiplied by its weighting factor. By increasing the relative weight assigned to a
region at risk, the user can place a greater emphasis upon reducing the dose to that
region. By increasing the relative weight assigned to the tumor, the user can place a
greater emphasis upon achieving a uniform target dose.
Another linear programming approach is to place both an upper and a lower
bound on the dose to the tumor. In this case, the objective might be to minimize a732 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
(a) The optimizer sought to minimize
the integral dose subject to a lower
bound on the tumor dose of 0.9.
(b) An upper bound of 1.1 and a lower
bound of 0.9 were placed on the tar-
get dose. The objective function was a
weighted integral dose.
(c) The dose is more evenly distributed
outside the tumor as a result of a con-
straint that the maximum beam weight
could not be more than a factor of 5
greater than the mean beam weight.
(d) The maximum deviation in dose
over the tumor was minimized subject
to the constraint that the mean dose to
the region at risk had to be kept below
0.5.
Fig. 4.2 A series of four dose distributions produced using linear programming techniques. In all
cases, 15 beam angles were used along with a collimator size of 6 mm; the dashed line
denotes the 90% isodose curve. The U-shaped target was cut out of a 5 cm by 5 cm square.
weighted integral dose summed over all of the nontumor pixels:
minw θN

(k,l)∈N Dkl + θR

(k,l)∈R Dkl
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),
γL ≤ Dkl ≤ γU ∀(k,l) ∈T,
wp ≥ 0.
γL and γU indicate the lower and upper bounds on the dose to the target. Figure 4.2(b)
displays a dose distribution produced using this approach with θN equal to 1 and θR
equal to 2.
When minimizing the integral dose, the highest weights are assigned to the beam-
lets that deposit the greatest fraction of their integral dose within the tumor. TheOPTIMIZING THE DELIVERY OF RADIATION THERAPY 733
results can become unsatisfactory if any of the beam weights is made exceedingly
large. Heavily weighted beams produce streaks of high dose through the patient, and
this could lead to patient complications. A solution to this problem is to place an
upper bound on the ratio between the maximum beam weight and the average beam
weight:
minw

(k,l)∈N Dkl + θ

(k,l)∈R Dkl
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),
γL ≤ Dkl ≤ γU ∀(k,l) ∈T,
wm ≤ α
n
n
p=1 wp,m =1 ,2,...,n,
wp ≥ 0.
In this case, the maximum beam weight could not exceed α times the mean beam
weight. In Figure 4.2(c), it can be seen that this approach resulted in a more evenly
distributed integral dose as compared to the previous linear programming optimiza-
tions.
A ﬁnal linear programming approach is to minimize the maximum deviation from
the prescribed target dose, δ, subject to one or more constraints. This can be accom-
plished using the following model:
minw max(i,j)∈T |Dij − δij|
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),
γL ≤ Dkl ≤ γU ∀(k,l) ∈T,

(r,s)∈R Drs ≤ nRβ,
wm ≤ α
n
n
p=1 wp,m =1 ,2,...,n,
wp ≥ 0.
In the above equation, nR is the number of pixels in R. An upper limit of β was
placed on the mean dose to the region at risk. Once again, the maximum beam weight
was constrained to be less than α times the mean beam weight. The technique used
to reformulate a minimax problem as a linear program has been well documented;
see [13], for example. Figure 4.2(d) shows an optimized dose distribution produced
with this model. Overall, the dose distribution in Figure 4.2(c) appears to be the best
linear programming result for this particular target shape.
The two primary advantages of the use of a linear programming approach to treat-
ment planning optimization are its speed and the ease of formulation. A disadvantage
of the linear programming formulations is a lack of ﬂexibility. One can only devise a
relatively limited number of objective functions and constraints that fall within the
linear realm. With any particular linear programming formulation, it is unlikely that
a physician could always achieve an acceptable result.
4.2. NonlinearProgrammingApproaches. A concise mathematical description
of the nonlinear programming (NLP) problem is as follows:
min f(x)
subject to g(x) ≤ 0,
  ≤ x ≤ u.734 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
Here, x is a vector of variables that are continuous real numbers, f(x) is the objective
function, and g(x) represents the set of constraints.   and u are vectors of lower and
upper bounds placed on the variables. With a nonlinear formulation [27], there is
an expanded range of possible objective functions and constraints as compared with
linear programming.
For many of our simulations, we have used a weighted least squares objective
function. In these cases, the optimizer sought to minimize the weighted squared
diﬀerences between the prescribed and the actual doses summed over all of the pixels.
The objective function is
min
w≥0
θT

(i,j)∈T
(Dij(w) − δij)2
+ θR

(i,j)∈R
(Dij(w) − δij)2 + θN

(i,j)∈N
(Dij(w) − δij)2.
As before, θT is the target weight, θR is the region at risk weight, and θN is the normal
tissue weight. The values of Dij(w) are determined using (4.1). For our simulations,
each weighting factor was normalized by the number of pixels in the region to which
the weight was assigned. This helps to eliminate diﬃculties with a large structure
dominating the optimization. The matrix δ describes the prescribed dose. Outside
the target, δ is typically set equal to zero. This problem is a bound-constrained
weighted least squares problem and can therefore be solved by various specialized
large-scale optimization algorithms [14, 42, 51, 52, 58].
Figure 4.3 displays two optimized dose distributions produced using diﬀerent
weighting schemes. In both cases, the target was prescribed a dose of 1. For a
particular patient, the best choice of weighting factors is not always intuitive. Thus,
in order to obtain an acceptable result, one may need to run a series of optimizations.
Ratio constraints on average and maximum beam intensities as well as other
bounding constraints outlined in section 4.1 give rise to general constrained nonlinear
programs. It should also be mentioned that nonlinear formulations have been used
by a number of researchers in an attempt to use mathematical models as a means of
predicting biological response. For example, researchers have devised mathematical
formulas that are designed to predict the probability of tumor control [72, 36]. For-
mulas have also been designed in hopes of predicting the probability of normal tissue
complications [38, 10, 37, 44, 34].
Ideally, this type of biological modeling could serve as a very useful tool in ra-
diotherapy optimization. For example, an oncologist could choose to maximize the
probability of tumor control subject to a cap placed upon the probability of com-
plications for each sensitive structure. Unfortunately, the current biological models
require input parameters that are not known with great certainty. The ability to pre-
dict the probability of normal tissue complications is particularly suspect. Because
of the degree of uncertainty involved, we have chosen not to include these models in
our current study.
From our investigations into NLP approaches, we have concluded that the primary
advantage of using this approach is that it is possible to devise numerous complicated
objective functions and constraints. A drawback to this approach (and those outlined
in the previous paragraph) is that increasing the complexity of the formulation will
often lead to more time-consuming optimizations. This is an area of future research.
Another weakness of the NLP approach is that for general functions, the optimizer
can only guarantee that the solution is locally optimal. The importance of multipleOPTIMIZING THE DELIVERY OF RADIATION THERAPY 735
(a) The target, region at risk, and nor-
mal tissue were assigned weights of 25,1,
and 1, respectively.
(b) The target, region at risk, and nor-
mal tissues were assigned weights of 10,
5, and 2.
(c) Cumulative dose volume histogram
for (a).
(d) Cumulative dose volume histogram
for (b).
Fig. 4.3 The results from two simulations are shown. In both cases, a weighted quadratic objective
function was used. Note that the tumor dose is more uniform when the tumor was assigned
a higher relative weight. The cumulative dose volume histogram plots the fraction of each
structure that receives at least the dose speciﬁed by the abscissa.
local minima in radiotherapy optimization has been investigated elsewhere [19, 35, 60].
Because of the potential to become stuck in a local minimum, a number of researchers
in radiotherapy optimization have made use of simulated annealing approaches [74,
73, 54]. It is our hope that a deterministic method will provide a more rapid approach
for developing a patient’s treatment plan. We believe that it is possible to develop
convex objective functions that adequately describe the problem. Note that the least
squares formulation presented above was convex. Thus, in this case, a locally optimal
solution is also globally optimal.
4.3. Partial Volume Constraints. Recall that the dose volume histogram (see
Figure 4.1) displays the fraction of each region of the patient that receives at least
a speciﬁed dose level. In some cases, the radiation oncologist is willing to sacriﬁce a
portion of a region at risk in order to improve the probability of curing the disease.
Oncologists often specify constraints of the form “No more than x% of this region736 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
(a) The error function used in our
implementation, f(x) = erf(x).
(b) A modiﬁed error function
(erf(x/3)); the factor of 3 in
the denominator creates a more
sloped ramp, f(x) = erf(x/3).
Fig. 4.4 Error functions used for partial volume constraints.
at risk can exceed a dose of y.” Thus, for a particular region at risk, the oncologist
determines both a dose limit and a fraction of the structure that can exceed the dose
limit. This type of requirement is called a partial volume constraint [53, 39].
For our formulas, the dose limit will be denoted by Λ and the fraction of the
volume allowed to exceed this limit will be denoted by Ω. We have tested both
a nonlinear and a mixed integer approach to the implementation of partial volume
constraints.
The nonlinear formulation represents a new approach to partial volume con-
straints:
minw

(i,j)∈T (Dij − δij)2
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),

(k,l)∈R erf(Dkl − Λkl) ≤ nRΩR,

(k,l)∈N erf(Dkl − Λkl) ≤ nNΩN,
wp ≥ 0.
In these formulas, nR is the number of pixels in the region at risk and nN is the
number of pixels in the normal tissue. The partial volume constraints were realized
through the use of a ramp function. In this case the error function (erf) was used (see
Figure 4.4(a)). For each partial volume constraint, the error function was shifted so
that the center of the ramp matched the dose limit. With other shifts and scalings
it may be possible to improve the solution quality and numerical performance. The
goal of the optimizer was to minimize the sum of the squared diﬀerence between the
prescribed and the actual doses over all of the pixels in the tumor subject to two
partial volume constraints.
Figure 4.5 shows the results of an optimization performed using this approach.
The geometry is the inverse of the L-shaped target used previously. In this case, the
arms of an L embrace a smaller, square-shaped target. This geometry was chosen in
order to eﬀectively test this implementation of partial volume constraints. For this
simulated treatment, the prescription dose level in the tumor was set at 70 Gy. TheOPTIMIZING THE DELIVERY OF RADIATION THERAPY 737
(a) optimized dose distribution (b) cumulative dose volume histogram
Fig. 4.5 Optimization using partial volume constraints implemented via a ramp function. In this
case, 20% of the region at risk was allowed to exceed 30 Gy and 5% of the region at risk was
allowed to exceed 50 Gy. The diamond on the dose volume histogram indicates the dose
volume histogram constraint applied to the critical structure, and the triangle indicates the
dose volume histogram constraint applied to the normal tissue.
ﬁrst partial volume constraint speciﬁed that 80% of the region at risk must be kept
below 30 Gy. The second partial volume constraint speciﬁed that 95% of the normal
tissue region must be kept below 50 Gy.
A scalar value can be placed in the denominator of the error function in order to
alter the slope of the curve (see Figure 4.4(b)). As the ramp function is made steeper,
the constraint becomes more absolute. It may be advisable to ﬁrst solve a problem
using a ramp function with a gradual slope. That solution can then be used as an
initial guess in an optimization using a steeper ramp function. One must be careful,
however, when choosing the scaling factor. If the slope of the ramp is too gradual,
the solution may diﬀer considerably from the desired results. On the other hand, a
ramp that is too steep may prove to be too diﬃcult for the optimization algorithm.
Both of these possibilities occurred in our experimentation. The results presented in
Figure 4.5 were produced using the error function depicted in Figure 4.4(a).
MIP makes possible a second approach to the implementation of partial volume
constraints. Mathematically, the MIP problem appears as follows:
min cTx + dTy
subject to Ax + By ≥ b,
  ≤ x ≤ u,
yi ∈{ 0,1,2,...},
wp ≥ 0.
In this formulation, x is a vector of variables that are continuous real numbers and y is
a vector of variables that can only take integer values, cTx+dTy is the linear objective
function, and Ax + By ≥ b represents the set of constraints.   and u are vectors of
lower and upper bounds placed on the continuous variables, and y ∈{ 0,1,2,...} is
the integrality requirement. Some related work using MIP formulations is described
in [39].
An optimized dose distribution produced using a mixed integer model is shown
in Figure 4.6. The goal of this optimization was to minimize the maximum deviation738 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
(a) optimized dose distribution (b) dose volume histogram
Fig. 4.6 An MIP implementation of partial volume constraints; here 15% of the critical structure
was allowed to exceed 30 Gy.
in dose over the target subject to a partial volume constraint that speciﬁed that 85%
(ΩR) of the region at risk must be maintained below the dose limit (Λ) of 30 Gy. This
constraint was modeled through the use of a binary variable Oij that equaled 1 if the
pixel in the region at risk exceeded the prescribed limit and 0 otherwise.
The following formulation was used to generate the simulated treatment:
minw max(i,j)∈T |Dij-δij|
subject to Dij =
n
p=1 wpD
p
ij ∀(i,j),
Dkl ≤ Λkl + M ∗ Okl,O k,l ∈{ 0,1}∀ (k,l) ∈R ,

(r,s)∈R Ors ≤ nRΩR,
wp ≥ 0.
The constraint
Dkl ≤ Λkl + M ∗ Okl,O k,l ∈{ 0,1}
is a standard MIP technique for modeling an “if-then” constraint. The value of M
is chosen to be large enough so that the corresponding constraint is trivially satisﬁed
when Okl = 1. In our case, the dose at any pixel is always less than 100 Gy, so we
typically set M equal to 100. Note that if Dkl exceeds Λkl, then Okl must be set equal
to 1. The variables Okl can then be used to enforce the partial volume constraint. In
the above case, the optimizer summed Ors over all of the pixels in the region at risk,
and it required that this value be less than ΩR times the total number of pixels in
the region at risk.
One appealing quality of partial volume constraints is that physicians are ex-
perienced with this type of requirement. Partial volume constraints are much more
intuitive than assigning relative weights to each region of the patient. A limitation
of the MIP implementation of partial volume constraints is that only linear objective
functions and linear constraints can be included in the optimization. With the ramp
function technique, however, any linear or nonlinear objective function or constraint
can be used. This, however, can lead to more complex and diﬃcult nonlinear pro-
grams that increase the probability of ﬁnding local solutions that are not globallyOPTIMIZING THE DELIVERY OF RADIATION THERAPY 739
(a) prescription (b) 7 beam angles
(c) 15 beam angles (d) 71 beam angles
Fig. 4.7 A series of conformal avoidance dose distributions. Note that a large number of beam
angles are needed to approach this diﬃcult prescription.
optimal. The primary disadvantage of partial volume constraints is that, due to the
complex formulation, each constraint can add considerable time to the optimization.
4.4. Conformal Avoidance. For a large number of radiotherapy patients, the
tumor volume is not clearly deﬁned. Thus, there is little rationale for attempting
to create a dose distribution that conforms tightly to the tumor volume. Instead, it
may be beneﬁcial to design a treatment that treats a regional ﬁeld while “conformally
avoiding” any critical structures in that ﬁeld. We have studied the possibility of using
intensity-modulated beams in order to deliver conformal avoidance radiotherapy.
The results from a series of simulations are shown in Figures 4.7 and 4.8. This
case utilized a U-shaped target with a prescribed relative dose of 7. A large nodal
region was prescribed a relative dose of 5. The goal of the optimization was to
produce a treatment plan that provided a uniform dose over both the target and the
nodal regions. Simultaneously, the optimizer attempted both to conformally avoid a
sensitive structure in the concavity of the U and to minimize the dose to the nonnodal
region.
It should be noted that ﬁnite source size and the phenomenon of electron trans-
port both cause a blurring of each beamlet. This blurring makes it impossible to740 D. SHEPARD, M. FERRIS, G. OLIVERA, AND T. MACKIE
(a) prescription (b) 7 beam angles
(c) 15 beam angles (d) 71 beam angles
Fig. 4.8 A series of cumulative dose volume histograms corresponding to the conformal avoidance
results shown in Figure 4.7.
exactly match the prescription. This is particularly true when the prescription calls
for adjacent pixels to receive dramatically diﬀerent dose levels.
From the perspective of optimization, conformal avoidance simulations represent
a particular challenge. In conventional treatments, the majority of potential beamlets
are removed from the optimization because they do not pass through the tumor. In
conformal avoidance, a large regional ﬁeld is treated. Thus, virtually all of the poten-
tial beamlets are used in the optimization. While the general form of the optimization
problems is the same as those described above, typically the weighting parameters are
changed and the amount of data involved is greatly increased.
One method to speed up conformal avoidance optimizations is to optimize over
a subset of the pixels. The optimization using 72 beam angles was performed over a
grid of points. A computation point was placed at every other pixel in both the x
and y directions. Thus, 75% of the pixels were excluded from the optimization.
From Figures 4.7 and 4.8, it can be seen that a large number of beam angles are
needed to successfully deliver conformal avoidance treatment plans.
5. Conclusions and Future Work. The ﬁeld of radiotherapy is currently in a
period of dramatic change. New treatment machines are providing the opportunity to
treat cancer patients with thousands of independently weighted beamlets of radiation.
The goal of this work has been to examine a number of mathematical models forOPTIMIZING THE DELIVERY OF RADIATION THERAPY 741
determining the optimal beam weights. Our simulated treatments have helped to
further our understanding of the advantages and disadvantages of linear, nonlinear,
and mixed integer approaches to optimizing each patient’s treatment plan.
The ﬂexibility provided by NLP is particularly appealing. The use of nonlinear
constraints in conjunction with a quadratic objective function should provide an on-
cologist with the ﬂexibility to produce an acceptable treatment plan for almost any
disease site.
A number of critical challenges remain. Clinical implementation of an optimiza-
tion approach requires a technique that is suitable for solving very large problems.
Actual patient cases will involve as many as 100,000 beamlets of radiation in a three-
dimensional setting. We believe that both model formulation and algorithmic im-
provements are necessary if problems of this size are to be solved in an acceptable
amount of time.
The ideal optimization approach should provide the ability to include partial vol-
ume constraints in an optimization model. We have tested both a nonlinear and a
mixed integer approach to partial volume constraints. Although these two approaches
have proven successful for small-scale problems, either technique can become exces-
sively time consuming in optimizing a real patient case. Similarly, the enormous
amount of data involved in the optimization of conformal avoidance treatments ne-
cessitates substantial computational advancements.
It is our hope that the community of optimization experts will be able to oﬀer fur-
ther insights that will improve our ability to solve these diﬃcult problems. For readers
interested in experimenting with these problems, the beamlet data sets along with the
code used to compute them are available at the Web site http://www.madrad.radiology.
wisc.edu.
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